3EOT image
Deposition Date 2008-09-29
Release Date 2009-01-20
Last Version Date 2024-10-30
Entry Detail
PDB ID:
3EOT
Keywords:
Title:
Crystal structure of LAC031, an engineered anti-VLA1 Fab
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:FAB FRAGMENT, HEAVY CHAIN
Mutations:W92I
Chain IDs:A (auth: H)
Chain Length:226
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:FAB FRAGMENT, LIGHT CHAIN
Chain IDs:B (auth: L)
Chain Length:215
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
Protein Eng.Des.Sel. 22 93 101 (2009)
PMID: 19074157 DOI: 10.1093/protein/gzn072

Abstact

A design approach was taken to investigate the feasibility of replacing single complementarity determining region (CDR) antibody loops. This approach may complement simpler mutation-based strategies for rational antibody design by expanding conformation space. Enormous crystal structure diversity is available, making CDR loops logical targets for structure-based design. A detailed analysis for the L1 loop shows that each loop length takes a distinct conformation, thereby allowing control on a length scale beyond that accessible to simple mutations. The L1 loop in the anti-VLA1 antibody was replaced with the L2 loop residues longer in an attempt to add an additional hydrogen bond and fill space on the antibody-antigen interface. The designs expressed well, but failed to improve affinity. In an effort to learn more, one design was crystallized and data were collected at 1.9 A resolution. The designed L1 loop takes the qualitatively desired conformation; confirming that loop replacement by design is feasible. The crystal structure also shows that the outermost loop (residues Leu51-Ser68) is domain swapped with another monomer. Tryptophan fluorescence measurements were used to monitor unfolding as a function of temperature and indicate that the loop involved in domain swapping does not unfold below 60 degrees C. The domain-swapping is not directly responsible for the affinity loss, but is likely a side-effect of the structural instability which may contribute to affinity loss. A second round of design was successful in eliminating the dimerization through mutation of a residue (Leu51Ser) at the joint of the domain-swapped loop.

Legend

Protein

Chemical

Disease

Primary Citation of related structures